TheraCryf PLC (TCF)

Currency in GBP
0.23
0.00(0.00%)
Closed·
TCF Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
TCF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.230.23
52 wk Range
0.201.25
Key Statistics
Bid/Ask
0.21 / 0.26
Prev. Close
0.23
Open
0.23
Day's Range
0.23-0.23
52 wk Range
0.2-1.25
Volume
400K
Average Volume (3m)
3.27M
1-Year Change
-67.14%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TCF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.19
Upside
+1,286.15%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

TheraCryf PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

TheraCryf PLC Company Profile

Theracryf Plc, a clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders. The company develops orexin-1 antagonist for the treatment of binge eating disorder and anxiety; and atypical dopamine transporter inhibitor (DAT) to treat fatigue and narcolepsy. It also develops SFX-01 for the treatment of brain cancer glioblastoma and neurodevelopmental disorders. The company was formerly known as Evgen Pharma plc and changed its name to Theracryf Plc in April 2024. Theracryf Plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.

Compare TCF to Peers and Sector

Metrics to compare
TCF
Peers
Sector
Relationship
P/E Ratio
−2.5x−6.0x−0.5x
PEG Ratio
−0.04−0.050.00
Price/Book
0.8x5.0x2.6x
Price / LTM Sales
-13.8x3.3x
Upside (Analyst Target)
-88.9%41.6%
Fair Value Upside
Unlock−13.4%5.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.19
(+1,286.15% Upside)

Earnings

Latest Release
Jun 03, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TCF Income Statement

FAQ

What Stock Exchange Does TheraCryf Trade On?

TheraCryf is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for TheraCryf?

The stock symbol for TheraCryf is "TCF."

What Is the TheraCryf Market Cap?

As of today, TheraCryf market cap is 4.90M.

What Is TheraCryf's Earnings Per Share (TTM)?

The TheraCryf EPS (TTM) is -0.00.

From a Technical Analysis Perspective, Is TCF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has TheraCryf Stock Split?

TheraCryf has split 1 times.

How Many Employees Does TheraCryf Have?

TheraCryf has 9 employees.

What is the current trading status of TheraCryf (TCF)?

As of 13 Aug 2025, TheraCryf (TCF) is trading at a price of 0.23, with a previous close of 0.23. The stock has fluctuated within a day range of 0.23 to 0.23, while its 52-week range spans from 0.20 to 1.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.